Corrigendum: O6-methylguanine DNA methyltransferase (MGMT) expression in U1242 glioblastoma cells enhances in vitro clonogenicity, tumor implantation in vivo, and sensitivity to alisertib-carboplatin combination treatment
Saved in:
| Main Authors: | Müge Sak, Brian J. Williams, Andrew J. Hey, Mayur Sharma, Leslie Schier, Megan J. Wilson, Mahatma Ortega, Alyssa I. Lara, Mikaela N. Brentlinger, Norman L. Lehman |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Cellular Neuroscience |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fncel.2025.1637837/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
O6-methylguanine DNA methyltransferase (MGMT) expression in U1242 glioblastoma cells enhances in vitro clonogenicity, tumor implantation in vivo, and sensitivity to alisertib-carboplatin combination treatment
by: Müge Sak, et al.
Published: (2025-04-01) -
A Pilocytic Astrocytoma Mimicking a Clinoidal Meningioma
by: Christopher S. Hong, et al.
Published: (2014-01-01) -
Radiomics prediction of MGMT promoter methylation in adult diffuse gliomas: a combination of structural MRI, DCE, and DTI
by: Yuying Liu, et al.
Published: (2025-01-01) -
MRI feature-based discrimination model for prediction of MGMT promoter methylation status in glioma
by: ZHANG Zhi-zhong, et al.
Published: (2025-07-01) -
Assessment of MGMT promoter methylation status in glioblastoma using deep learning features from multi-sequence MRI of intratumoral and peritumoral regions
by: Xuan Yu, et al.
Published: (2024-12-01)